Artificial Intelligence could be a lifeline but unsuccessful trials, limited opportunities, and lack of experience is holding healthcare professionals back…
As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast cancer patients may be considered…
Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Approval…
NEW DELHI and LONDON and MUNICH, Jan. 28, 2025 /PRNewswire/ -- Datar Cancer Genetics (DCG) has launched a revolutionary video-reporting…
Photo credit: Dentzz Dental MUMBAI, India, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Dentzz Dental, a leading provider of advanced dental…
January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast on Monday, January 27, 2025, at 8:00 a.m.…
Photo credit: Dentzz Dental MUMBAI, India, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Dentzz Dental, a leading provider of advanced dental…
January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast on Monday, January 27, 2025, at 8:00 a.m.…
Photo credit: Dentzz Dental MUMBAI, India, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Dentzz Dental, a leading provider of advanced dental…
January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast on Monday, January 27, 2025, at 8:00 a.m.…